+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Apellis Pharmaceuticals - logo

Apellis Pharmaceutical was founded in 2009 in Crestwood, U.S.A. It is a company with the aim of innovating and creating products to treat autoimmune and inflammatory diseases. Our lead compounds are designed to broadly inhibit complement C3, which is the central protein in the complement system.The complement system plays a key role in a wide range of autoimmune and inflammatory diseases. They believe with the use of C3 inhibition it may correct the immunological dysfunction. The approach they apply to this process is known as complement immunotherapy.

From
Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021 - Product Thumbnail Image

Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021

  • Drug Pipelines
  • September 2021
  • 1013 Pages
From
From
From
Warm Autoimmune Hemolytic Anemia (WAIHA) - Pipeline Insight, 2020 - Product Thumbnail Image

Warm Autoimmune Hemolytic Anemia (WAIHA) - Pipeline Insight, 2020

  • Clinical Trials
  • September 2020
  • 70 Pages
From
From
Lupus Nephritis - Pipeline Insight, 2021 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2021

  • Clinical Trials
  • July 2021
  • 90 Pages
From
From
Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2022 - Product Thumbnail Image

Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2022

  • Clinical Trials
  • March 2022
  • 80 Pages
From
From
Loading Indicator